Evidence map›Paper›PMID 35762185›Full record

ArticleKorean journal of radiology2022

Phase I Clinical Trial of Prostate-Specific Membrane Antigen-Targeting

Minseok Suh, Hyun Gee Ryoo, Keon Wook Kang, Jae Min Jeong, Chang Wook Jeong, Cheol Kwak, Gi Jeong Cheon

Open access · hybridAbstract readClinical Trial, Phase I
PubMed Full text at PMC Publisher
In one paragraph

Article in Korean journal of radiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Minseok SuhDepartment of Nuclear Medicine, Seoul National University College of Medicine, Seoul, Korea.ORCID 0000-0002-6932-8552
Hyun Gee RyooDepartment of Nuclear Medicine, Seoul National University College of Medicine, Seoul, Korea.ORCID 0000-0001-5020-5846
Keon Wook KangDepartment of Nuclear Medicine, Seoul National University College of Medicine, Seoul, Korea.ORCID 0000-0003-2622-9017
Jae Min JeongDepartment of Nuclear Medicine, Seoul National University College of Medicine, Seoul, Korea.ORCID 0000-0003-2611-6020
Chang Wook JeongDepartment of Urology, Seoul National University College of Medicine, Seoul, Korea.ORCID 0000-0002-2200-5019
Cheol KwakDepartment of Urology, Seoul National University College of Medicine, Seoul, Korea.ORCID 0000-0002-1987-2111
Gi Jeong CheonDepartment of Nuclear Medicine, Seoul National University College of Medicine, Seoul, Korea.ORCID 0000-0002-1360-5186
Seoul National University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveMATERIALS AND

methodsWe designed a prospective, open-label, single-arm clinical trial with two cohorts comprising six healthy adult men and six patients with metastatic prostate cancer. Safety and blood test-based toxicities were monitored throughout the study. PET/CT scans were acquired at multiple time points after administering

resultsAll 12 participants (six healthy adults aged 31-32 years and six prostate cancer patients aged 57-81 years) completed the clinical trial. No drug-related adverse events were observed. In the healthy adult group,

conclusion

Indexed as

Positron Emission Tomography Computed TomographyProstatic NeoplasmsAdultGallium RadioisotopesHealthy VolunteersHumansMaleProspective StudiesProstateGallium RadioisotopesDosimetryPET/CTProstate cancerPSMA

Identifiers

PMID35762185
PMCPMC9434735
OpenAlexW4283709798

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.